However, four tumor markers (POSTN, pSMAD2/3, CXCL14, ADH1B, FAP) that have previously been reported to predict suboptimal debulking were selected in our model, although only p-SMAD2/3 was in the same direction but with lower discriminatory performance compared to prior reports. The gene discussed is FAP; the disease is neoplasm.